Skip to the page

Data / Crowdfunding / California / CerMed Corp

CerMed Corp: crowdfunding raise on StartEngine Primary, LLC, $19,999 to $1,235,000 (2025)

CerMed Corp, a corporation in Salinas, CA, filed a Form C with the SEC on March 21, 2025 to raise $19,999 to $1,235,000 in common stock through StartEngine Primary, LLC. The offering closed on April 30, 2025. In its most recent fiscal year it reported $0 in revenue and a net loss of $852,284, with 4 employees.

SpecStream is the live web data engine for teams and agents. It reads every Form C on SEC EDGAR each morning, and this page is that reading. Ask for your own cut (a portal, a state, a size, a revenue range) and new raises arrive in your sheet, CRM, Slack or agent as they land.

Website
www.oncogenx.com
Funding portal
StartEngine Primary, LLC
Address
397C CORRAL DE TIERRA SUITE 309C, Salinas, CA 93908
Legal form
Corporation
Jurisdiction
DE
Incorporated
August 21, 2008
SEC CIK
0001458574

Offering terms

From the amendment filed March 21, 2025.

Security
Common Stock
Price
$0.95
Target
$19,999
Maximum
$1,235,000
Deadline
April 30, 2025
Portal compensation
7 - 13 percent

Financials

From the Form C-U filed May 12, 2025.

Most recent fiscal yearPrior fiscal yearSource
Revenue$0$7,672sec.gov
Cost of goods sold$142$2,977sec.gov
Net income$-852,284$-1,371,294sec.gov
Taxes paid$0$0sec.gov
Total assets$144,034$145,958sec.gov
Cash$12,395$175sec.gov
Accounts receivable$0$0sec.gov
Short-term debt$1,833,836$1,298,741sec.gov
Long-term debt$519,000$519,000sec.gov

Filings

FiledFilingTargetMaximumDeadlineNoteSource
May 12, 2025Progress update$19,999$1,235,000April 30, 2025Adjustment to the initial Form C-U filing. At the close of the offering, the issuer closed on $110,791.89 and 132,176 number of securities.sec.gov
April 18, 2025Progress update$19,999$1,235,000April 30, 2025The issuer has raised over 50% ($112,368.03) of the offering target amount ($123999.70).sec.gov
March 21, 2025Amendment$19,999$1,235,000April 30, 2025Removed J. Fernandez, added C. Calarco as Pres CEO. Added risk re $595K liens lawsuits. Corrected FDA reg. of iPap (De Novo). Added future rev. disclaimers. Removed $114K notes. CEO time split. Lowered min. goal, extended deadline.sec.gov
January 8, 2025Offering$123,999$1,235,000April 8, 2025sec.gov

All filings on sec.gov

Updated May 12, 2025. Read from SEC EDGAR. Public domain (U.S. government work). Financials are as each company reported them in its Form C, unaudited unless the filing says otherwise. Websites are the ones the companies declared to the SEC. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.